Microbiologists find source of fungus's damaging growth

Sep 22, 2010
This is an image of hyphal Candida albicans cells. This fungus attacks patients with weakened immune systems. It also causes yeast infections and oral thrush. Credit: David Kadosh, Ph.D., UT Health Science Center San Antonio

Candida albicans, a fungus that kills more than 10,000 people with weakened immune systems each year, grows more dangerous as it forms and extends long strands of cells called hyphal filaments. In a paper published this month, UT Health Science Center San Antonio microbiologists describe a key factor involved in this damaging growth.

This finding may eventually lead to targets for antifungal strategies, the scientists said.

Patricia Carlisle, a Ph.D. student at the Health Science Center, and David Kadosh, Ph.D., assistant professor of microbiology, found that Ume6, a key transcriptional regulator, targets a specific hyphal filament-development mechanism. "No one knew that Ume6 was involved in directing this process," Dr. Kadosh said. "Perhaps we can learn how to mute its signals."

Transcriptional regulators direct the conversion of DNA () into RNA copies. Copies of RNA () are translated into proteins that carry out activity.

Bug's impact

preys on hospitalized critical care patients, HIV/AIDS patients, and others with weakened immune systems. It is the fourth-leading cause of hospital-acquired infections in the United States.

"The forming of hyphal filaments is very important in tissue invasion and other activities," Dr. Kadosh said.

The findings were featured as a Spotlight article in the September issue of Eukaryotic Cell, a journal of the American Society for Microbiology.

Explore further: New insights in survival strategies of bacteria

More information: Eukaryotic Cell journal article: ec.asm.org/cgi/reprint/9/9/1320

Provided by University of Texas Health Science Center at San Antonio

4 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

New Way to Fight Fungal Infection

Jun 23, 2009

(PhysOrg.com) -- A team of researchers led by Amy G. Hise, M.D., M.P.H., assistant professor at the Center for Global Health and Diseases at Case Western Reserve University's School of Medicine, has discovered how the body ...

Breast cancer drug shows promise against serious infections

Jul 20, 2009

An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer. ...

Mounting a multi-layered attack on fungal infections

Sep 08, 2009

Unravelling a microbe's multilayer defence mechanisms could lead to effective new treatments for potentially lethal fungal infections in cancer patients and others whose natural immunity is weakened.

Vitamin B3 as a novel approach to treat fungal infections

Jul 08, 2010

A team of scientists from the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal have identified vitamin B3 as a potential antifungal treatment. Led by IRIC Principal Investigators ...

Recommended for you

New insights in survival strategies of bacteria

9 hours ago

Bacteria are particularly ingenious when it comes to survival strategies. They often create a biofilm to protect themselves from a hostile environment, for example during treatment with antibiotics. A biofilm is a bacterial ...

Team makes scientific history with new cellular connection

Sep 11, 2014

Researchers led by Dr. Helen McNeill at the Lunenfeld-Tanenbaum Research Institute have revealed an exciting and unusual biochemical connection. Their discovery has implications for diseases linked to mitochondria, ...

Researchers discover new producer of crucial vitamin

Sep 11, 2014

(Phys.org) —New research has determined that a single group of micro-organisms may be responsible for much of the world's vitamin B12 production in the oceans, with implications for the global carbon cycle and climate change.

How bacteria battle fluoride

Sep 11, 2014

He's not a dentist, but Christopher Miller is focused on fluoride. Two studies from his Brandeis University lab provide new insights into the mechanisms that allow bacteria to resist fluoride toxicity, information ...

User comments : 0